Cargando…

Relationships between Sclerostin, Leptin and Metabolic Parameters in Non-Dialysis Chronic Kidney Disease Males

Sclerostin is an inhibitor of the Wnt-beta-catenin pathway. The relationship between sclerostin and adipose tissue or between sclerostin and nutritional status has been the subject of research interest in the last decade. Sclerostin concentrations are elevated in patients with chronic kidney disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romejko, Katarzyna, Rymarz, Aleksandra, Szamotulska, Katarzyna, Bartoszewicz, Zbigniew, Niemczyk, Stanisław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864785/ https://www.ncbi.nlm.nih.gov/pubmed/36675692 http://dx.doi.org/10.3390/jpm13010031

Ejemplares similares

Left Ventricular Diastolic Dysfunction in Chronic Kidney Disease Patients Not Treated with Dialysis
por: Romejko, Katarzyna, et al.
Publicado: (2022)

Resistin Contribution to Cardiovascular Risk in Chronic Kidney Disease Male Patients
por: Romejko, Katarzyna, et al.
Publicado: (2023)

Serum Osteoprotegerin Is an Independent Marker of Left Ventricular Hypertrophy, Systolic and Diastolic Dysfunction of the Left Ventricle and the Presence of Pericardial Fluid in Chronic Kidney Disease Patients
por: Romejko, Katarzyna, et al.
Publicado: (2022)

Serum Osteoprotegerin Is an Independent Marker of Metabolic Complications in Non-DialysisDependent Chronic Kidney Disease Patients
por: Rymarz, Aleksandra, et al.
Publicado: (2021)

Comparison of Skinfold Thicknesses and Bioimpedance Spectroscopy to Dual-Energy X-Ray Absorptiometry for the Body Fat Measurement in Patients With Chronic Kidney Disease
por: Rymarz, Aleksandra, et al.
Publicado: (2017)

Testosterone Deficiency as One of the Major Endocrine Disorders in Chronic Kidney Disease
por: Romejko, Katarzyna, et al.
Publicado: (2022)

Changes of Hemodynamic Parameters after Intradialytic Glucose Injection
por: Niemczyk, Longin, et al.
Publicado: (2023)

Is Free Testosterone Concentration a Prognostic Factor of Survival in Chronic Renal Failure (CRF)?
por: Niemczyk, Stanisław, et al.
Publicado: (2015)

First year survival of patients on maintenance dialysis treatment in Poland
por: Brodowska-Kania, Dorota, et al.
Publicado: (2015)

Visceral Adipose Tissue is Associated with Insulin Resistance in Hemodialyzed Patients
por: Giers, Kinga, et al.
Publicado: (2015)

Homeostatic model assessment indices in evaluation of insulin resistance and secretion in hemodialysis patients
por: Niemczyk, Stanisław, et al.
Publicado: (2013)

Assessment of the correlation of commonly used laboratory tests with clinical activity, renal involvement and treatment of systemic small-vessel vasculitis with the presence of ANCA antibodies
por: Mosakowska, Magdalena, et al.
Publicado: (2021)

Testosterone Deficiency and Nutritional Parameters as Predictors of All-Cause Mortality among Male Dialysis Patients
por: Leśniak, Ksymena, et al.
Publicado: (2022)

Melatonin Treatment in Kidney Diseases
por: Markowska, Magdalena, et al.
Publicado: (2023)

Low Free Triiodothyronine as a More Sensitive Predictor of Survival Than Total Testosterone among Dialysis Men
por: Leśniak, Ksymena, et al.
Publicado: (2023)

Protein energy-wasting associated with nephrotic syndrome – the comparison of metabolic pattern in severe nephrosis to different stages of chronic kidney disease
por: Matyjek, Anna, et al.
Publicado: (2020)

The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL)
por: Romejko, Katarzyna, et al.
Publicado: (2023)

The complex treatment including rituximab in the Management of Catastrophic Antiphospholid Syndrome with renal involvement
por: Rymarz, Aleksandra, et al.
Publicado: (2018)

Early and Late Acute Kidney Injury in Severely Burned Patients
por: Witkowski, Wojciech, et al.
Publicado: (2016)

Comparable Hemodilution with Hypertonic Glucose in Patients with and without Type-2 Diabetes Mellitus during Hemodialysis
por: Schneditz, Daniel, et al.
Publicado: (2023)

Heart Metastases of Clear Cell Renal Cell Carcinoma
por: Romejko, Katarzyna, et al.
Publicado: (2023)

Advanced Chronic Kidney Disease is a Strong Predictor of Hypogonadism and is Associated with Decreased Lean Tissue Mass
por: Skiba, Ryszard, et al.
Publicado: (2020)

The significance of metalloproteinase 3 (MMP-3), chemokine CXC ligand 13 (CXCL-13) and complement component C5a in different stages of ANCA associated vasculitis
por: Rymarz, Aleksandra, et al.
Publicado: (2021)

Cardiovascular Response to Intravenous Glucose Injection during Hemodialysis with Assessment of Entropy Alterations
por: Niemczyk, Longin, et al.
Publicado: (2022)

Impaired Kidney Function Associated with Increased Risk of Side Effects in Patients with Small Vessel Vasculitis Treated with Rituximab as an Induction Therapy
por: Rymarz, Aleksandra, et al.
Publicado: (2021)

Application of dynamic optimisation for planning a haemodialysis process
por: Stecz, Wojciech, et al.
Publicado: (2019)

Noninfectious, Severe Cryoglobulinemic Vasculitis with Renal Involvement – Safety and Efficacy of Long-Term Treatment with Rituximab
por: Leśniak, Ksymena, et al.
Publicado: (2021)

Ultrasonic evaluation of renal cortex arterial area enables differentiation between hypertensive and glomerulonephritis-related chronic kidney disease
por: Lubas, Arkadiusz, et al.
Publicado: (2017)

Nutritional Status, Selected Nutrients Intake and Their Relationship with the Concentration of Ghrelin and Adiponectin in Patients with Diabetic Nephropathy
por: Boniecka, Iwona, et al.
Publicado: (2021)

Testosterone Replacement Therapy in Chronic Kidney Disease Patients
por: Skiba, Ryszard, et al.
Publicado: (2022)

Low lean tissue mass can be a predictor of one-year survival in hemodialysis patients
por: Rymarz, Aleksandra, et al.
Publicado: (2018)

Ocular Involvement of Granulomatosis with Polyangiitis
por: Byszewska, Anna, et al.
Publicado: (2023)

Age-related differences in the quality of life in end-stage renal disease in patients enrolled in hemodialysis or continuous peritoneal dialysis
por: Laudański, Krzysztof, et al.
Publicado: (2013)

Association of sclerostin with cardiovascular events and mortality in dialysis patients
por: Zou, Yun, et al.
Publicado: (2020)

Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome—A Single Center Prospective Study
por: Matyjek, Anna, et al.
Publicado: (2021)

Associations between Sclerostin and Anthropometric and Metabolic Parameters in Children and Adolescents
por: Kim, Shin-Hee, et al.
Publicado: (2021)

Vancomycin dosing in patients undergoing maintenance hemodialysis
por: Rymarz, Aleksandra, et al.
Publicado: (2014)

An Insight Into the Association of Sclerostin With Insulin Sensitivity and Glycemic Parameters in Male Indian Prediabetic and Diabetic Population
por: Singh, Praveen K, et al.
Publicado: (2022)

Effect of Chronic Kidney Disease on Changes in Vasopressin System Expression in the Kidney Cortex in Rats with Nephrectomy
por: Czarzasta, Katarzyna, et al.
Publicado: (2018)

Sclerostin
por: Silverman, Stuart L.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_h15ouvs48iunuko91io6ehg7od